Video

Laura Topor Discusses Challenges of e-Prescribing Specialty Medications

Prescribers and pharmacies can encounter some unique challenges when specialty drugs are e-prescribed, but organizations like the National Council for Prescription Drug Programs are trying to make the process smoother, explained Laura Topor, president of Granada Health.

Prescribers and pharmacies can encounter some unique challenges when specialty drugs are e-prescribed, but organizations like the National Council for Prescription Drug Programs (NCPDP) are trying to make the process smoother, explained Laura Topor, president of Granada Health.

Transcript (slightly modified)

What are the challenges of e-prescribing specialty medications, and how can they be overcome?

I’ve spent a fair amount of time through NCPDP trying to improve the standard to support e-prescribing of specialty medications, and what we’ve found is there were a lot of elements on that intake or enrollment form that a specialty pharmacy has that weren’t included. They maybe would send the prescription and still be faxing the form in, so we’ve enhanced the standard, which will be available when the new regulations come out that allow us to use it, that will simplify that process. We added things like gestational age and hospice indicators and IV administration elements.

The other challenge is often because of where the product can be dispensed, and the prescriber doesn’t know that, so we’re trying to figure that piece out to make sure that the prescription gets to the right pharmacy. We’ve got some work to do there, but it’s… Who’s going to get that prior authorization? Is the right information moving? Is it going to a pharmacy; is it going to a hub? All of those components we’re trying to address in enhancing the e-prescribing transactions.

Related Videos
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
 Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Dr Cesar Davila-Chapa
Screenshot of an interview with Nadine Barrett, PhD
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo